Increase/Decrease in Cash (Annual)

Increase/Decrease in Cash: The total change in cash for the company over the given period.

West Pharmaceutical Services, Inc. (WST) had Increase/Decrease in Cash of $306.70M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$3.07B
Net Income	$493.70M
Cost of Goods Sold	$1.97B
Gross Profit	$1.10B
Operating Expenses	$2.49B
Operating Income	$584.90M
Non-Operating Income/Expense	$16.00M
Pre-Tax Income	$600.90M
Normalized Pre-Tax Income	$600.90M
Income after Taxes	$479.30M
Income from Continuous Operations	$493.70M
Consolidated Net Income/Loss	$493.70M
Normalized Income after Taxes	$479.30M
EBIT	$584.90M
EBITDA	$756.30M
Weighted-Average Shares Outstanding (Basic)	72.30M
Weighted-Average Shares Outstanding (Diluted)	72.70M
Earnings per Share (EPS) (Basic)	$6.83
Earnings per Share (EPS) (Diluted)	$6.79
Balance Sheet Financials
Current Assets	$1.98B
Property, Plant, and Equipment	$1.73B
Long-Term Assets	$2.29B
Total Assets	$4.27B
Current Liabilities	$654.90M
Long-Term Debt	$202.80M
Long-Term Liabilities	$439.10M
Total Liabilities	$1.09B
Common Equity	$3.18B
Tangible Shareholders Equity	$3.06B
Shareholders Equity	$3.18B
Common Shares Outstanding	72.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$754.80M
Cash Flow from Investing Activities	$-285.90M
Cash Flow from Financial Activities	$-185.10M
Beginning Cash	$484.60M
End Cash	$791.30M
Increase/Decrease in Cash	$306.70M
Stock-Based Compensation	$23.80M
Common Stock Dividends Paid	$-61.20M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.06
Gross Margin	35.91%
Operating Margin	19.03%
EBIT Margin	19.03%
EBITDA Margin	24.60%
Pre-Tax Profit Margin	19.55%
Profit Margin	16.06%
Free Cash Flow	$468.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.72
Inventory Turnover	4.44
Receiveable Turnover	5.35
Days Sales in Receivables	68.20
Return on Equity	15.54%
Return on Tangible Equity	16.14%
Return on Assets	11.56%
Return on Investments	14.61%
Book Value Per Share	$44.11
Free Cash Flow per Share	$6.45
Operating Cash Flow per Share	$10.38

Data from Zacks Investment Research, Inc.